Karyopharm Therapeutics (KPTI) EGM 2026 summary

Opening remarks and agenda

• Meeting called to order at 9:00 A.M. Eastern Time on February 18, 2026, in a virtual format, ensuring stockholders' participation rights.

• Michael Mano appointed as secretary and inspector of election; oath filed with meeting minutes.

• Rules of conduct and procedures for participation and questions outlined at the start.

Specific resolutions to be voted on

• Proposal One: Amendment to increase authorized capital stock from 58,333,333 to 111 million and common stock from 53,333,333 to 106 million.

• Proposal Two: Approval to adjourn the meeting if necessary to solicit more proxies for Proposal One.

Corporate governance

• Notice of meeting and proxy statement sent to all stockholders of record as of December 29, 2025.

• Quorum established with majority of voting power present or represented by proxy.